27659310|t|Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans
27659310|a|Streptococcus mutans forms biofilms as a resistance mechanism against antimicrobial agents in the human oral cavity. We recently showed that human cathelicidin LL-37 exhibits inhibitory effects on biofilm formation of S. mutans through interaction with lipoteichoic acid (LTA), but without antibacterial or biofilm dispersal abilities. (-)-Epigallocatechin gallate (EGCG) is the most abundant constituent of tea catechins that has the greatest anti-infective potential to inhibit the growth of various microorganisms and biofilm formation. Therefore, in this study, we evaluated whether LL-37 interacts with EGCG to enhance the antibiofilm effect of EGCG on S. mutans biofilm formation. Clinical S. mutans strains (n = 10) isolated from children's saliva were tested in a biofilm formation assay. The antibiofilm effect of EGCG with and without LL-37 was analyzed by the minimum biofilm eradication concentration assay and confirmed using field emission-scanning electron microscopy. In addition, the interaction among EGCG, LL-37, and LTA of S. mutans was determined using quartz crystal microbalance analysis. EGCG killed 100 % of planktonic S. mutans within 5 h, inhibited biofilm formation within 24 h, and reduced bacteria cells in preformed biofilms within 3 h at a concentration of 0.2 mg/mL. However, EGCG did not appear to interact with LTA. LL-37 effectively enhanced the bactericidal activity of EGCG against biofilm formation and preformed biofilms as determined by quantitative crystal violet staining and field emission-scanning electron microscopy. In addition, quartz crystal microbalance analysis revealed that LL-37 interacted with EGCG and promoted binding between EGCG and LTA of S. mutans. We show that LL-37 enhances the antibiofilm effect of EGCG on S. mutans. This finding provides new knowledge for dental treatment by using LL-37 as a potential antibiofilm compound.
27659310	0	24	Human cathelicidin LL-37	T103	UMLS:C3891304
27659310	37	55	antibiofilm effect	T033	UMLS:C0243095
27659310	59	63	EGCG	T103	UMLS:C0059438
27659310	67	87	Streptococcus mutans	T007	UMLS:C0038409
27659310	88	108	Streptococcus mutans	T007	UMLS:C0038409
27659310	115	123	biofilms	T007	UMLS:C0081786
27659310	158	178	antimicrobial agents	T103	UMLS:C1136254
27659310	186	191	human	T204	UMLS:C0086418
27659310	192	203	oral cavity	T082	UMLS:C0226896
27659310	229	253	human cathelicidin LL-37	T103	UMLS:C3891304
27659310	285	302	biofilm formation	T038	UMLS:C1325881
27659310	306	315	S. mutans	T007	UMLS:C0038409
27659310	341	358	lipoteichoic acid	T103	UMLS:C0065067
27659310	360	363	LTA	T103	UMLS:C0065067
27659310	378	391	antibacterial	T033	UMLS:C0243095
27659310	395	402	biofilm	T007	UMLS:C0081786
27659310	403	422	dispersal abilities	T082	UMLS:C0332624
27659310	424	452	(-)-Epigallocatechin gallate	T103	UMLS:C0059438
27659310	454	458	EGCG	T103	UMLS:C0059438
27659310	496	499	tea	T168	UMLS:C0039400
27659310	500	509	catechins	T103	UMLS:C0007404
27659310	532	556	anti-infective potential	T033	UMLS:C0243095
27659310	560	578	inhibit the growth	T038	UMLS:C2249823
27659310	609	626	biofilm formation	T038	UMLS:C1325881
27659310	657	666	evaluated	T058	UMLS:C0220825
27659310	675	680	LL-37	T103	UMLS:C3891304
27659310	696	700	EGCG	T103	UMLS:C0059438
27659310	716	734	antibiofilm effect	T033	UMLS:C0243095
27659310	738	742	EGCG	T103	UMLS:C0059438
27659310	746	755	S. mutans	T007	UMLS:C0038409
27659310	756	773	biofilm formation	T038	UMLS:C1325881
27659310	784	793	S. mutans	T007	UMLS:C0038409
27659310	836	842	saliva	T031	UMLS:C0036087
27659310	860	877	biofilm formation	T038	UMLS:C1325881
27659310	878	883	assay	T058	UMLS:C0005507
27659310	889	907	antibiofilm effect	T033	UMLS:C0243095
27659310	911	915	EGCG	T103	UMLS:C0059438
27659310	933	938	LL-37	T103	UMLS:C3891304
27659310	943	951	analyzed	T062	UMLS:C0936012
27659310	967	974	biofilm	T007	UMLS:C0081786
27659310	1001	1006	assay	T058	UMLS:C0005507
27659310	1033	1070	emission-scanning electron microscopy	T058	UMLS:C0026020
27659310	1107	1111	EGCG	T103	UMLS:C0059438
27659310	1113	1118	LL-37	T103	UMLS:C3891304
27659310	1124	1127	LTA	T103	UMLS:C0065067
27659310	1131	1140	S. mutans	T007	UMLS:C0038409
27659310	1162	1198	quartz crystal microbalance analysis	T062	UMLS:C2936414
27659310	1200	1204	EGCG	T103	UMLS:C0059438
27659310	1221	1231	planktonic	T007	UMLS:C0032071
27659310	1232	1241	S. mutans	T007	UMLS:C0038409
27659310	1264	1281	biofilm formation	T038	UMLS:C1325881
27659310	1307	1321	bacteria cells	T007	UMLS:C0004611
27659310	1335	1343	biofilms	T007	UMLS:C0081786
27659310	1397	1401	EGCG	T103	UMLS:C0059438
27659310	1434	1437	LTA	T103	UMLS:C0065067
27659310	1439	1444	LL-37	T103	UMLS:C3891304
27659310	1470	1491	bactericidal activity	T038	UMLS:C0544570
27659310	1495	1499	EGCG	T103	UMLS:C0059438
27659310	1508	1525	biofilm formation	T038	UMLS:C1325881
27659310	1540	1548	biofilms	T007	UMLS:C0081786
27659310	1579	1593	crystal violet	T103	UMLS:C0017440
27659310	1594	1602	staining	T058	UMLS:C0487602
27659310	1613	1650	emission-scanning electron microscopy	T058	UMLS:C0026020
27659310	1665	1701	quartz crystal microbalance analysis	T062	UMLS:C2936414
27659310	1716	1721	LL-37	T103	UMLS:C3891304
27659310	1738	1742	EGCG	T103	UMLS:C0059438
27659310	1756	1763	binding	T038	UMLS:C1167622
27659310	1772	1776	EGCG	T103	UMLS:C0059438
27659310	1781	1784	LTA	T103	UMLS:C0065067
27659310	1788	1797	S. mutans	T007	UMLS:C0038409
27659310	1812	1817	LL-37	T103	UMLS:C3891304
27659310	1831	1849	antibiofilm effect	T033	UMLS:C0243095
27659310	1853	1857	EGCG	T103	UMLS:C0059438
27659310	1861	1870	S. mutans	T007	UMLS:C0038409
27659310	1912	1928	dental treatment	T058	UMLS:C0011331
27659310	1938	1943	LL-37	T103	UMLS:C3891304
27659310	1959	1979	antibiofilm compound	T103	UMLS:C1254351